Dana farber pancreatic cancer clinical trials
WebA major focus of his research is in developing therapies that exploit double-strand DNA damage repair (DDR) deficiency in metastatic pancreatic adenocarcinoma. He is currently is leading a phase 2 clinical trial of the PARP inhibitor Niraparib in pancreatic cancer patients with DNA repair deficiencies. WebOur Research Clinical Trials Find a Clinical Trial Print Email Back Phase II Trial of ERK Inhibition Alone and in Combination with Autophagy Inhibition in Patients with Metastatic Pancreatic Cancer Enrolling 877-DF-TRIAL (877-338-7425) Trial ID: NCT04386057 View complete trial on ClinicalTrials.gov Protocol #: 19-529
Dana farber pancreatic cancer clinical trials
Did you know?
WebPanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country. Baylor College of Medicine (Houston, TX) Principal investigator: Benjamin Musher, MD Cedars-Sinai Medical Center (Los Angeles, CA)
WebThe Haigis Lab at Dana-Farber studies the big questions in cancer biology using tools from the complementary fields of molecular biology, molecular in vivo imaging, mouse modelling, proteomics, structural biology, computational biology, and in vivo imaging. WebAug 5, 2024 · Alongside the clinical trial, the MIT team plans to analyze which types of pancreatic tumors might respond best to this drug combination. They are also doing …
WebThe Haigis lab is seeking a highly motivated, bachelor’s level graduate who will support our laboratory as a research technician in the Department of Cancer Biology at Dana … WebDana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion ...
WebApr 13, 2024 · The American Cancer Society, the largest non-government, non-profit funding source of cancer research in the United States, has approved funding for 90 …
WebJul 14, 2024 · This is a randomized multicentre phase II trial with a large translational component. The trial will evaluate the two standard chemotherapy regimens: modified … hopper how to craftWebThe opening of Dana-Farber Brigham Cancer Center - Foxborough, located… The Institute’s newest clinical site welcomed its first patients … loo in britishWebApr 13, 2024 · Effective treatments are urgently needed for pancreatic cancer, one of the deadliest cancers in the U.S. Dr. Winter’s group has initiated a clinical trial investigating an anti-IDH1 drug in combination with chemotherapy in patients … loo informally crosswordWebFeb 27, 2024 · Evaluate the preliminary clinical efficacy of palbociclib and gedatolisib in the following expansion cohorts: 1) advanced squamous cell lung cancer, 2) advanced pancreatic cancer, 3) advanced head & neck cancer, and 4) any tumor with presumed PI3K-pathway dependence using CT and MRI scans per RECIST version 1. looijmans houthandelWebFive cancer centers are pooling patient data and samples for this collaboration, including Beth Israel Deaconess Medical Center (Boston, MA), Columbia University Medical … looiman starter final formsWebClinical Trials Sponsored by Dana-Farber Cancer Institute Total 35 results ‹ 1 2 3 4 5 6 7 8 9 10 ... 32 33 › NCT05800366 Not yet recruiting A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma Lymphoma Lymphoma, Large B-Cell, Diffuse NCT05796570 Not yet recruiting looing at a macbook togetherWebHave questions about joining a clinical trial? To request information about a clinical trial, call our dedicated clinical trials navigator line at 212-342-5162 or email us at [email protected]. You can also contact us … hopper hydraulics